Ketamine is a medicine used as an anesthetic. It helps people fall asleep quickly and stay asleep during surgery. It's also sometimes used to treat depression or pain.
Every report comes from a Lived member, sent anonymously.
Have you tried Ketamine for CRPS (Complex Regional Pain Syndrome)?
Ketamine is a general anesthetic, sold as an injection under the brand name Ketalar and as generic ketamine. Its use approved by the US Food and Drug Administration (FDA) is anesthesia: it can be the only anesthetic for some short procedures, start anesthesia before other agents take over, or add to other anesthetics. At lower doses, ketamine is also used off-label, meaning for purposes the FDA has not approved. Hospitals give it to control severe short-term pain, sometimes to reduce the amount of opioid medicine needed. Clinics also give it by infusion for depression that has not improved with standard treatments. The FDA has not approved ketamine for depression or any other psychiatric condition. A related product, Spravato (esketamine), is different. It is a nasal spray containing one of the two mirror-image forms of the ketamine molecule, and it is FDA approved for adults with treatment-resistant depression and for depression with acute suicidal thoughts or behavior. It is given only in certified clinics, with monitoring afterward.
Glutamate is the brain's main excitatory chemical messenger, and one of the places it acts is the NMDA (N-methyl-D-aspartate) receptor on nerve cells. Ketamine blocks this receptor. At anesthetic doses, that blocking action produces deep sedation and pain relief along with a sense of being disconnected from the body and surroundings, which is why ketamine is called a dissociative anesthetic. At lower doses the same action dampens pain signaling, which is why it can help with severe acute pain. Why ketamine can lift depression within hours, when standard antidepressants take weeks, is still being studied, and blocking this one receptor is not thought to explain the effect fully.
Ketamine is given by a clinician, usually into a vein (intravenously) and sometimes as a shot into a muscle. The dose depends on body weight and purpose: anesthesia uses much higher doses than pain or depression treatment. For anesthesia, it is given only by teams trained to manage the airway, with continuous monitoring and emergency breathing equipment ready. For depression, a typical approach in research and clinics is a low-dose infusion over about 40 minutes, given in a course of sessions (for example twice a week for a few weeks). Blood pressure, heart rate and alertness are checked during and after each session. People need someone to take them home, and should not drive, operate machinery or do other hazardous activities for 24 hours afterward.
During and shortly after a dose, many people feel detached from their body or surroundings (dissociation), see vivid dream-like images, or feel dizzy, confused or nauseated. Blood pressure and heart rate usually rise for a short time. As people wake from anesthesia, about 1 in 8 have an emergence reaction such as confusion, agitation or hallucinations, which generally lasts a few hours. Double vision and vomiting can also occur. With repeated or long-term use, ketamine can damage the bladder and urinary tract and, less often, the liver and bile ducts. Bladder problems can show up as pain when urinating, needing to urinate often or urgently, or blood in the urine. Report these symptoms to the prescriber promptly, since stopping ketamine early can allow recovery. Mood or perception changes that persist for days after a dose should also be reported promptly.
Combining ketamine with opioids, benzodiazepines (sedatives such as lorazepam or alprazolam), alcohol or other sedating drugs can cause deep sedation and dangerously slowed breathing, and has caused coma and death. Avoid alcohol around treatment and make sure the care team knows about every sedating medicine. Ketamine is avoided in people for whom a significant rise in blood pressure would be dangerous, such as those with poorly controlled high blood pressure or certain heart and blood vessel conditions. Ketamine is a Schedule III controlled substance with real potential for misuse and dependence, especially for people with a history of substance use problems. The FDA has warned that compounded ketamine sold for at-home use as tablets, lozenges or nasal sprays is not FDA approved, has not been checked for safety, effectiveness or quality, and lacks a clinician monitoring for heavy sedation, dissociation and blood pressure changes. Pregnancy and breastfeeding need a specific discussion: outside of anesthesia, ketamine use while breastfeeding is not recommended, and data on use during most of pregnancy are lacking. For children 3 and under, lengthy or repeated anesthesia raises concerns about brain development that families can weigh with the surgical team.
After anesthesia, the deepest effects wear off fairly quickly, but drowsiness and unsteadiness can linger, which is the reason for the 24-hour driving rule. When used for pain in the hospital, it is usually one part of a broader plan and is stopped once the pain is manageable. For depression, some people feel better within a day of an infusion, which is the main reason it draws interest. In a large trial of people with treatment-resistant depression, a three-week course of twice-weekly infusions worked as well as electroconvulsive therapy (ECT). But not everyone responds, and the effect of a single infusion usually fades within about two weeks, so ongoing sessions are often needed to keep the benefit. Long-term safety and the best maintenance schedule are not well studied. If treatment continues over months, expect periodic questions about urinary symptoms and blood tests to check the liver.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Ketamine, what you've noticed, or ask the community a question.